000143325 001__ 143325
000143325 005__ 20240229112548.0
000143325 0247_ $$2doi$$a10.1007/s00401-019-01987-0
000143325 0247_ $$2WOS$$aWOS:000462124800012
000143325 0247_ $$2ISSN$$a0001-6322
000143325 0247_ $$2ISSN$$a1432-0533
000143325 0247_ $$2altmetric$$aaltmetric:56726065
000143325 0247_ $$2pmid$$apmid:30848347
000143325 037__ $$aDKFZ-2019-00915
000143325 082__ $$a610
000143325 1001_ $$aEllison, David W.$$b0
000143325 245__ $$acIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation
000143325 260__ $$aHeidelberg$$bSpringer$$c2019
000143325 3367_ $$2DRIVER$$aarticle
000143325 3367_ $$2DataCite$$aOutput Types/Journal article
000143325 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1575291554_22045$$xLetter
000143325 3367_ $$2BibTeX$$aARTICLE
000143325 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143325 3367_ $$00$$2EndNote$$aJournal Article
000143325 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000143325 588__ $$aDataset connected to Web of Science, Web of Science, , CrossRef
000143325 7001_ $$aHawkins, Cynthia$$b1
000143325 7001_ $$0P:(DE-He78)551bb92841f634070997aa168d818492$$aJones, David$$b2$$udkfz
000143325 7001_ $$aOnar-Thomas, Arzu$$b3
000143325 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan$$b4$$udkfz
000143325 7001_ $$aReifenberger, Guido$$b5
000143325 7001_ $$aLouis, David N.$$b6
000143325 773__ $$0PERI:(DE-600)1458410-4$$a10.1007/s00401-019-01987-0$$gVol. 137, no. 4, p. 683 - 687$$n4$$p683 - 687$$tActa neuropathologica$$v137$$x1432-0533$$y2019
000143325 909CO $$ooai:inrepo02.dkfz.de:143325$$pVDB
000143325 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)551bb92841f634070997aa168d818492$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000143325 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000143325 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000143325 9141_ $$y2019
000143325 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000143325 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bACTA NEUROPATHOL : 2017
000143325 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143325 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143325 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000143325 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000143325 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000143325 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143325 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000143325 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143325 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143325 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000143325 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000143325 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bACTA NEUROPATHOL : 2017
000143325 9201_ $$0I:(DE-He78)B360-20160331$$kB360$$lPediatric Glioma$$x0
000143325 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lPädiatrische Neuroonkologie$$x1
000143325 980__ $$ajournal
000143325 980__ $$aVDB
000143325 980__ $$aI:(DE-He78)B360-20160331
000143325 980__ $$aI:(DE-He78)B062-20160331
000143325 980__ $$aUNRESTRICTED